‘Worst decision I ever made’

Kate Moss’ sister issued a warning to anyone taking Ozempic after the English model was rushed to hospital.

Lottie, 26, admitted she took Ozempic for two weeks “a few months ago”.

At the time, she did not feel “happy” about her weight.

“I had a friend and she could get it for me,” Lottie explained during an episode of her “Dream On with Lottie Moss” podcast.

“It was a little bit lower… It was from a doctor, but it wasn’t like you go to the doctor’s office, and he gives you a prescription, takes your blood pressure and does tests, which is what you need when you’re on something like Ozempic .”

The British model admitted that Ozempic “wasn’t intended for the weight loss of people who are not a very large size”.

Ozempic, also known as semaglutide, was originally developed for patients with type 2 diabetes, but has been widely used for weight loss.

“When I was getting it, the amount I was getting was actually meant for people who are [220 pounds] and on, and I’m on [110] verse,” said Lottie.

“So it’s these little things I wish I knew before I got it.”

Lottie then encouraged listeners not to take Ozempic.

“When I tell you it was the worst decision I’ve ever made, so if this is a warning to anyone: Please, if you’re thinking about taking it, don’t take it, it’s not worth it,” Lottie said.


Lottie Moss attends Raffaello Summer Day 2024 on June 18, 2024 in Berlin, Germany.
The model admitted to taking Ozempic for two weeks “a few months ago”. Getty Images

“I’d rather die any day than have it again. It made me feel so nauseous.”

After repeatedly throwing up, Lottie lost nearly 20 pounds.

“I think I started around [132 pounds]and I went down to [125 pounds] with the first dose, then I went down to like [119 pounds]. It was madness. I think it was the lowest [116 pounds]. In terms of a few weeks, that’s not a healthy weight loss and that’s not a healthy drop.”


A general view of an Ozempic package and Ozempic injection applicator pen as seen in Hawthorne, NJ on April 14, 2024.
Moss knew she didn’t need Ozempic and admitted the drug wasn’t for “people who aren’t very large,” but she explained further on the “Dream On with Lottie Moss” podcast that a friend took it for to. . Christopher Sadowski

She continued, “When I was in bed for those two days, and it was kind of the end of it, and I just wanted to get off it — because it’s not like you can stop taking it, it’s not like a pill or something that you don’t take when you wake up in the morning, it’s in your system and it’s there.”

“I felt very sick one day and I said to my friend: “I can’t hold water, I can’t hold food, no liquids, nothing. I have to go to the hospital, I feel very ill.’

Lottie claimed she eventually paid a visit to the emergency room where the 26-year-old model had a seizure due to dehydration.

A spokesperson for Ozempic manufacturer Novo Nordisk told Fox News Digital in a statement, “We understand and empathize with the health challenges this patient has faced. While we cannot comment on this particular incident, we care deeply about the safety and well-being of patients taking our medications and strongly recommend that all patients keep in close contact with their healthcare professional for proper diagnosis, treatment proper, continuous and careful instructions. monitoring.”

It was also noted “that Ozempic® (semaglutide injection) is for patients with type 2 diabetes and is a prescription-only medicine, which means it must be prescribed by a healthcare professional and must be taken as prescribed under supervision his strict. Patients should make any treatment decisions together with their healthcare professional, so that their doctor can assess whether it is appropriate to prescribe the drug or not, based on their assessment of the individual medical profile of the patient. Taking prescription-only drugs without a valid prescription poses a direct health risk.”

“Above all, patient safety is our top priority at Novo Nordisk. We work closely with the US Food and Drug Administration and all regulatory agencies worldwide to continuously monitor the safety profile of our drugs,” the statement concluded.

#Worst #decision
Image Source : nypost.com

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top